Multiple sclerosis (MS) is
a complex inflammatory and demyelinating disease of central nervous system
(CNS). The disease pathogenesis is not fully understood and no actual cure for
the disease yet. The disease has genetic and environmental cause as fundamental
factors which are identified for the disease pathogenesis so far. One of the characteristic
features of the disease is inflammation cause due to activation of pro-inflammatory
cells. Interference in signalling pathways such as JAK/STAT could result in
physiological or pathological outcome in MS. Dysregulation of JAK/STAT
signalling pathway is associated with chronic inflammatory process and immune
disorders. In this review, considering the important role of JAK/STAT pathway
in signal transduction of inflammatory process and immune responses in CNS, we describe the involvement of this signal transduction pathway in MS. Moreover,
we consider the physiological and pathological involvement of JAK/STAT rout in neurogenesis/gliogenesis,
cytokines production and as therapeutics target for managing MS.
Cite this paper
Hamid, K. M. , Isiyaku, A. , Kalgo, M. U. , Yahaya, I. S. and Mirshafiey, A. (2017). JAK-STAT Lodges in Multiple Sclerosis: Pathophysiology and Therapeutic Approach Overview. Open Access Library Journal, 4, e3492. doi: http://dx.doi.org/10.4236/oalib.1103492.
Hernández-Pedro,
N.Y., Espinosa-Ramirez, G., Pérez de la Cruz, V., Pineda, B. and Sotelo, J. (2013) Initial Immunopathogenesis of Multiple Sclerosis:
Innate Immune Response. Clinical
and Developmental Immunology, 2013, Article ID: 413465.
Stadelmann, C. (2011) Multiple Sclerosis as a Neurodegenerative
Disease: Pathology, Mechanisms and Therapeutic Implications. Current Opinion
in Neurology, 24, 224-229. https://doi.org/10.1097/WCO.0b013e328346056f
Oksenberg,
J.R., Baranzini, S.E., Sawcer, S. and Hauser, S.L. (2008) The Genetics of Multiple Sclerosis:
SNPs to Pathways to Pathogenesis. Nature Reviews Genetics, 9, 516-526. https://doi.org/10.1038/nrg2395
Martins, T.B., Rose, J.W., Jaskowski, T.D, Wilson, A.R., Husebye, D. and Seraj, H.S. (2011) Analysis of Proinflammatory and Anti-Inflammatory Cytokine Serum Concentrations in Patients with Multiple Sclerosis by Using
a Multiplexed Immunoassay. American
Journal of Clinical Pathology, 136, 696-704. https://doi.org/10.1309/AJCP7UBK8IBVMVNR
Batoulis,
H., Addicks, K. and Kuerten, S. (2010) Emerging Concepts in Autoimmune
Encephalomyelitis beyond the CD4/TH1 Paradigm. Annals of Anatomy, 192, 179-193.
Ramagopalan, S.V., Dobson, R., Meier,
U.C. and Giovannoni, G. (2010) Multiple Sclerosis: Risk Factors,
Prodromes and Potential Causal Pathways. TheLancet
Neurology, 9,
727-739. https://doi.org/10.1016/S1474-4422(10)70094-6
Romme,
C.J., Bornsen, L., Hesse, D., Krakauer, M. Sorensen, P.S. and Sondergaard, H.B. (2012) Cellular Sources of Dysregulated
Cytokines in Relapsing-Remitting Multiple Sclerosis. Journal of Neuroinflammation, 9, 215.
Kasper, L.H. and Shoemaker, J. (2010) Multiple Sclerosis Immunology:
The Healthy Immune System vs the Multiple Sclerosis Immune System. Neurology, 74, S2-S8. https://doi.org/10.1212/WNL.0b013e3181c97c8f
Rodgers,
J.M. and Miller, S.D. (2012) Cytokine Control of Inflammation and Repair in the Pathology of Multiple Sclerosis. Yale Journal of Biology and Medicine, 85, 447-468.
Nicolas, C.S.,
Amici, M., Bortolotto, Z.A., Doherty, A., Csaba, Z., Fafouri, A., Dournaud, P.,
Gressens, P., Collingridge, G.L. and Peineau, S. (2013) The Role of JAK-STAT Signaling
within the Central Nervous System. JAK-STAT, 2, e22925. https://doi.org/10.4161/jkst.22925
Furqan,
M., Mukhi, N., Lee, B. and Liu, D. (2013) Dysregulation of JAK-STAT pathway
in Hematological Malignancies and JAK Inhibitors for Clinical Application. Biomarker
Research, 1, 5. https://doi.org/10.1186/2050-7771-1-5
Campbell,
I.L. (2005) Cytokine-Mediated Inflammation, Tumorogenesis, and Disease-Associated
JAK/STAT/SOCS Signaling Circuits in the Central Nervous System. Brain Research
Reviews, 48, 166-177.
O’Sullivan, L.A., Liongue, C., Lewis, R.S., Stephenson, S.E. and Ward, A.C. (2007) Cytokine Receptor Signaling through the Jak-Stat-Socs
Pathway in Disease. Molecular Immunology,
44, 2497-2506.
Mohr, A., Chatain, N., Domoszlai,
T., Rinis, N., Sommerauer, M., Vogt, M. and Müller-Newen,
G. (2012) Dynamics and Non-Canonical
Aspects of JAK/STAT Signalling. European Journal
of Cell Biology, 91, 524-532.
Santos, C.I. and Costa-Pereira,
A.P. (2011) Signal Transducers and Activators of Transcription—From Cytokine Signalling
to Cancer Biology. Biochimica et Biophysica Acta, 1816, 38-49.
Benveniste, E.N., Liu, Y., McFarland,
B.C. and Qin, H. (2014) Involvement of the Janus Kinase/Signal Transducer
and Activator of Transcription Signaling Pathway in Multiple Sclerosis and the Animal
Model of Experimental Autoimmune Encephalomyelitis. Journal of Interferon and Cytokine Research, 34, 577-588. https://doi.org/10.1089/jir.2014.0012
O’Shea,
J.J. and Plenge,
R. (2012) JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated
Disease. Immunity, 36, 542-550. https://doi.org/10.1016/j.immuni.2012.03.014
Cao,
F., Hata, R., Zhu, P., Nakashiro, K. and Sakanaka, M. (2010) Conditional Deletion of STAT3
Promotes Neurogenesis and Inhibits Astrogliogenesis in Neural Stem Cells. Biochemical
and Biophysical Research Communications,394, 843-847.
He,
F., Ge, W., Martinowich, K., Becker-Catania, S., Coskun, V., Zhu, W., Wu, H., Castro,
D., Guillemot, F., Fan, G., de Vellis, J. and Sun, Y.E. (2005) A Positive Autoregulatory Loop
of JAK-STAT Signaling Controls the Onset of Astrogliogenesis. Nature Neuroscience,
8, 616-625. https://doi.org/10.1038/nn1440
de la Iglesia, N., Puram, S.V. and Bonni, A. (2009) STAT3 Regulation of Glioblastoma Pathogenesis. Current Molecular Medicine, 9,
580-590. https://doi.org/10.2174/156652409788488739
Herrmann,
J.E., Imura, T., Song, B., Qi, J., Ao, Y., Nguyen, T.K., Korsak, R.A., Takeda,
K., Akira, S. and Sofroniew, M.V. (2008) STAT3
Is a Critical Regulator of Astrogliosis and Scar Formation After Spinal Cord Injury. Journal of Neuroscience, 28, 7231-7243. https://doi.org/10.1523/JNEUROSCI.1709-08.2008
Kisseleva, T., Bhattacharya, S., Braunstein, J. and
Schindler, C.W. (2002) Signaling through the JAK/STAT Pathway, Recent Advances
and Future Challenges. Gene, 285, 1-24.
Srivastava,
P., Mujtaba, M.A. and Singhal, M. (2012) Gene and Cytokines Expression
of Multiple Sclerosis and Its Therapeutic Regimen: A Systemic Review. International
Journal of Drug Development and Research, 4, 55-66.
Valentino,
L. and Pierre,
J. (2006) JAK/STAT Signal Transduction: Regulators and Implication in Hematological
Malignancies. Biochemical Pharmacology, 71, 713- 721.
Vera, J., Rateitschak, K., Lange, F., Kossow, C.,
Wolkenhauer, O. and Jaster, R. (2011) Systems Biology of JAK-STAT
Signalling in Human Malignancies. Progress in Biophysics and Molecular
Biology, 106, 426-434.
Cayre, M.,
Canoll, P. and Goldman,
J.E. (2009) Cell Migration in the Normal and Pathological Postnatal Mammalian Brain. Progress in Neurobiology,
88, 41-63.
Gómez-Nicola,
D., Valle-Argos, B., Pallas-Bazarra, N. and Nieto-Sampedro, M. (2011) Interleukin-15 Regulates
Proliferation and Self-Renewal of Adult Neural Stem Cells. Molecular Biology
of the Cell, 22, 1960-1970. https://doi.org/10.1091/mbc.E11-01-0053
Bonni,
A., Sun, Y., Nadal-Vicens, M., Bhatt, A., Frank, D.A., Rozovsky, I., Stahl, N., Yancopoulos,
G.D. and Greenberg, M.E. (1997) Regulation of Gliogenesis in the Central Nervous System
by the JAK-STAT Signaling Pathway. Science, 278, 477- 483. https://doi.org/10.1126/science.278.5337.477
Garza,
J.C., Guo, M., Zhang, W. and Lu, X.Y. (2008) Leptin Increases Adult Hippocampal
Neurogenesis in Vivo and in Vitro. Journal of Biological Chemistry, 283, 18238-18247. https://doi.org/10.1074/jbc.M800053200
Kim, Y.H., Chung, J.I., Woo, H.G., Jung, Y.S., Lee, S.H., Moon,
C.H., Suh-Kim, H. and Baik, E.J. (2010) Differential
Regulation of Proliferation and Differentiation in Neural Precursor Cells by the
JAK Pathway. Stem Cells,
28, 1816-1828. https://doi.org/10.1002/stem.511
Müller,
S., Chakrapani, B.P., Schwegler, H., Hofmann, H.D. and Kirsch,
M. (2009) Neurogenesis in the Dentate Gyrus Depends on Ciliary Neurotrophic Factor
and Signal Transducer and Activator of Transcription 3 Signaling. Stem Cells, 27, 431- 441. https://doi.org/10.1634/stemcells.2008-0234
Hirsch,
M., Knight, J., Tobita, M., Soltys, J., Panitch, H. and Mao-Draayer,
Y. (2009) The Effect of Interferon-Beta on Mouse Neural Progenitor Cell Survival
and Differentiation. Biochemical and Biophysical Research Communications,388, 181-186.
Lum, M., Croze, E., Wagner, C., McLenachan, S., Mitrovic, B. and Turnley,
A.M. (2009) Inhibition of Neurosphere Proliferation by IFN-Gamma but Not IFN Beta
Is Coupled to Neuronal Differentiation. Journal
of Neuroimmunology, 206, 32-38. https://doi.org/10.1016/j.jneuroim.2008.10.009
Mangoura,
D., Pelletiere, C., Leung, S., Sakellaridis, N. and Wang,
D.X. (2000) Prolactin Concurrently Activates Src-PLD and JAK/Stat Signaling Pathways
to Induce Proliferation While Promoting Differentiation in Embryonic Astrocytes. International Journal of Developmental Neuroscience, 18,
693-704.
Gupta, S., Mishra, K., Surolia, A. and Banerjee,
K. (2011) Suppressor of Cytokine Signalling-6 Promotes Neurite Outgrowth via JAK2/STAT5-Mediated
Signalling Pathway, Involving Negative Feedback Inhibition. PLoS ONE, 6,
e26674. https://doi.org/10.1371/journal.pone.0026674
M?kel?,
J., Koivuniemi, R., Korhonen, L. and Lindholm, D. (2010) Interferon- Gamma
Produced by Microglia and the Neuropeptide PACAP Have Opposite Effects on the Viability
of Neural Progenitor Cells. PLoS ONE, 5, e11091. https://doi.org/10.1371/journal.pone.0011091
Schwaiger,
F.W., Hager, G., Schmitt, A.B., Horvat, A., Hager, G., Streif, R., Spitzer, C., Gamal, S., Breuer, S., Brook,
G.A., Nacimiento, W. and Kreutzberg, G.W. (2000) Peripheral
but Not Central Axotomy Induces Changes in Janus Kinases (JAK) and Signal Transducers
and Activators of Transcription (STAT). European
Journal of Neuroscience, 12, 1165-1176. https://doi.org/10.1046/j.1460-9568.2000.00005.x
Smith,
P.D., Sun, F., Park, K.K., Cai,
B., Wang, C., Kuwako, K., Martinez-Carrasco, I.,
Connolly, L. and He, Z. (2009) SOCS3 Deletion Promotes Optic Nerve Regeneration in Vivo. Neuron, 64, 617-623. https://doi.org/10.1016/j.neuron.2009.11.021
Greve,
B., Weissert, R., Hamdi, N., Bettelli, E., Sobel, R.A., Coyle, A., Kuchroo, V.K.,
Rajewsky, K. and Schmidt-Supprian, M. (2007) IκB Kinase 2/β Deficiency Controls Expansion of Autoreactive T Cells and Suppresses
Experimental Autoimmune Encephalomyelitis. Journal of Immunology, 179, 179-185. https://doi.org/10.4049/jimmunol.179.1.179
Nishikomori,
R., Usui, T., Wu, C.Y., Morinobu, A., O’Shea, J.J. and Strober,
W. (2002) Activated STAT4 Has an Essential Role in Th1 Differentiation and Proliferation
That Is Independent of Its Role in the Maintenance of IL-12R Beta 2 Chain Expression
and Signaling. Journal of Immunology,169,
4388-4398. https://doi.org/10.4049/jimmunol.169.8.4388
Nishibori, T., Tanabe, Y., Su, L. and David, M. (2004) Impaired Development of CD4 CD25 Regulatory
T Cells in the Absence of STAT1: Increased Susceptibility to Autoimmune Disease. Journal of Experimental
Medicine, 199, 25-34. https://doi.org/10.1084/jem.20020509
Liu,
X., Lee, Y.S., Yu, C.R. and Egwuagu,
C.E. (2008) Loss of STAT3 in CD4 T Cells Prevents Development of Experimental
Autoimmune Diseases. Journal of Immunology,
180, 6070-6076. https://doi.org/10.4049/jimmunol.180.9.6070
Liao,
W., Lin, J.X., Wang, L., Li,
P. and Leonard, W.J. (2011) Modulation of Cytokine Receptors
by IL-2 Broadly Regulates Differentiation into Helper T Cell Lineages. Nature
Immunology, 12, 551-559. https://doi.org/10.1038/ni.2030
Stritesky,
G.L., Muthukrishnan, R., Sehra, S., Goswami, R., Pham, D., Travers, J., Nguyen, E.T., Levy, D.E. and Kaplan, M.H. (2011) The Transcription Factor STAT3 Is Required for T Helper
2 Cell Development. Immunity, 34
39-49. https://doi.org/10.1016/j.immuni.2010.12.013
Carpentier,
P.A., Duncan, D.S. and Miller, S.D. (2008) Glial Toll-Like Receptor Signaling
in Central Nervous System Infection and Autoimmunity. Brain, Behavior, and Immunity, 22, 140-147. https://doi.org/10.1016/j.bbi.2007.08.011
Flavell, R.A., Sanjabi, S., Wrzesinski, S.H. and Licona-Limon, P. (2010) The Polarization of Immune Cells in the Tumour Environment by TGF
Beta. Nature Review Immunology,
10, 554-567. https://doi.org/10.1038/nri2808
Cao, L. and He, C. (2013) Polarization of Macrophages
and Microglia in Inflammatory Demyelination. Neuroscience Bulletin, 29, 189-198. https://doi.org/10.1007/s12264-013-1324-0
Lawrence, T. and Natoli, G. (2011) Transcriptional Regulation of Macrophage Polarization: Enabling Diversity
with Identity. Nature Review Immunology, 11, 750-761. https://doi.org/10.1038/nri3088
Jiang, Z., Li, H., Fitzgerald, D.C., Zhang, G.Z. and Rostami,
A. (2009) MOG35-55 i.v Suppresses Experimental Autoimmune Encephalomyelitis
Partially through Modulation of Th17 and JAK/STAT Pathways. European Journal of Immunology, 39, 789-799. https://doi.org/10.1002/eji.200838427
Bettelli,
E., Korn, T. and Kuchroo, V.K. (2007) Th17: The Third Member of
the Effector T Cell Trilogy. Current
Opinion in Immunology, 19, 652-657. https://doi.org/10.1016/j.coi.2007.07.020
Jadidi-Niaragh,
F. and Mirshafiey,
A. (2011) Th17 Cell, the New Player of Neuroinflammatory Process in Multiple Sclerosis. Scandinavian Journal of Immunology, 74, 1-13. https://doi.org/10.1111/j.1365-3083.2011.02536.x
Iwakura,
Y. and Ishigame,
H. (2006) The IL-23/IL-17 Axis in Inflammation. Journal of Clinical Investigation, 116, 1218-1222. https://doi.org/10.1172/JCI28508
Huppert,
J., Closhen, D., Croxford, A., White, R., Kulig, P., Pietrowski, E., Bechmann, I., Becher,
B., Luhmann, H.J., Waisman,
A. and Kuhlmann, C.R. (2010) Cellular Mechanisms of IL-17-Induced Blood-Brain Barrier
Disruption. FASEB Journal, 24, 1023-1034. https://doi.org/10.1096/fj.09-141978
Tzartos,
J.S., Friese, M.A., Craner, M.J., Palace, J., Newcombe, J., Esiri, M.M. and Fugger, L. (2008) Interleukin-17 Production in Central Nervous System-Infiltrating
T Cells and Glial Cells Is Associated with Active Disease in Multiple Sclerosis. American Journal of Pathology,
172, 146-155. https://doi.org/10.2353/ajpath.2008.070690
Komiyama,
Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K. and Iwakura, Y. (2006) IL-17 Plays
an Important Role in the Development of Experimental Autoimmune Encephalomyelitis. Journal of Immunology, 177,
566- 573. https://doi.org/10.4049/jimmunol.177.1.566
Fitzgerald,
D.C., Ciric, B., Touil, T., Harle, H., Grammatikopolou, J., Das Sarma, J., Gran, B., Zhang, G.X. and Rostami, A. (2007) Suppressive Effect of IL-27 on Encephalitogenic Th17
Cells and the Effector Phase of Experimental Autoimmune Encephalomyelitis. Journal of Immunology, 179, 3268-3275. https://doi.org/10.4049/jimmunol.179.5.3268
Stromnes,
I.M., Cerretti, L.M., Liggitt, D., Harris, R.A. and Goverman,
J.M. (2008) Differential Regulation of Central Nervous System Autoimmunity by TH1
and TH17 Cells. Nature Medicine, 14, 337-342. https://doi.org/10.1038/nm1715
Camporeale, A. and Poli, V. (2012) IL-6, IL-17
and STAT3: A Holy Trinity in Auto-Immunity? Frontiers in Bioscience, 17, 2306-2326. https://doi.org/10.2741/4054
Yang,
X.P., Ghoreschi, K., Steward-Tharp, S.M., Rodriguez-Canales, J., Zhu, J., Grainger,
J.R., Hirahara, K., Sun,
H.W., Wei, L., Vahedi,
G., Kanno, Y., O’Shea,
J.J. and Laurence, A. (2011) Opposing Regulation of the Locus Encoding IL-17 through
Direct, Reciprocal Actions of STAT3 and STAT5. Nature Immunology, 12, 247-254. https://doi.org/10.1038/ni.1995
Durant,
L., Watford, W.T., Ramos, H.L., Laurence, A., Vahedi, G., Wei, L., Takahashi, H., Sun, H.W., Kanno, Y., Powrie,
F. and O’Shea, J.J. (2010) Diverse Targets of the Transcription Factor STAT3 Contribute
to T Cell Pathogenicity and Homeostasis. Immunity, 32, 605-615. https://doi.org/10.1016/j.immuni.2010.05.003
El-Kasmi,
K.C., Holst, J., Coffre, M., Mielke, L., de Pauw, A., Lhocine, N., Smith, A.M., Rutschman,
R., Kaushal, D., Shen,
Y., Suda, T., Donnelly,
R.P., Myers Jr., M.G., Alexander, W., Vignali, D.A., Watowich,
S.S., Ernst, M., Hilton,
D.J. and Murray, P.J. (2006) General Nature of the STAT3-Activated Anti-Inflammatory
Response. Journal of Immunology, 177,
7880-7888. https://doi.org/10.4049/jimmunol.177.11.7880
Burchill,
M.A., Yang, J., Vogtenhuber, C., Blazar, B.R. and Farrar, M.A. (2007) IL-2 Receptor Beta-Dependent
STAT5 Activation Is Required for the Development of Foxp3 Regulatory
T Cells. Journal of Immunology, 178, 280-290. https://doi.org/10.4049/jimmunol.178.1.280
Chen,
Y., Haines, C.J., Gutcher, I., Hochweller, K., Blumenschein, W.M., McClanahan, T., H?mmerling, G., Li,
M.O., Cua, D.J. and McGeachy, M.J. (2011) Foxp3 Regulatory T Cells Promote T Helper 17 Cell Development in Vivo through Regulation of Interleukin-2. Immunity, 34, 409-421. https://doi.org/10.1016/j.immuni.2011.02.011
Lin, Y., Wang, F. and Zhang, G.L. (2014) Natural Products and Their Derivatives
Regulating the Janus Kinase/Signal Transducer and Activator of Transcription Pathway. Journal of Asian Natural Products and Research, 16, 800-812. https://doi.org/10.1080/10286020.2014.929573
Bright,
J.J., Du, C. and Sriram, S. (1999) Tyrphostin B42 Inhibits IL12-Induced
Tyrosine Phosphorylation and Activation of Janus Kinase-2 and Prevents Experimental
Allergic Encephalomyelitis. Journal of Immunology,162, 6255-6262.
Liu, Y., Holdbrooks, A.T., De Sarno, P., Rowse, A.L., Yanagisawa, L.L., McFarland, B.C. and Harringt, L.E. (2014) Therapeutic
Efficacy of Suppressing the JAK/STAT Pathway in Multiple Models of EAE. Journal of Immunology, 192, 59-72. https://doi.org/10.4049/jimmunol.1301513
Van
Vollenhoven, R.F., Fleischmann, R., Cohen, S., Lee, E.B., Garcia Meijide, J.A., Wagner, S. Forejtova, S., Zwillich,
S.H., Gruben, D., Koncz,
T., Wallenstein, G.V.,
Krishnaswami, S., Bradley, J.D. and Wilkinson, B. (2012) Tofacitinib or Adalimumab versus Placebo in Rheumatoid
Arthritis. The
New
England Journal of Medicine, 367, 508-519. https://doi.org/10.1056/NEJMoa1112072
Muthian,
G., Raikwar, H.P., Rajasingh, J. and Bright, J.J. (2006) 1,25 Dihydroxyvitamin-D3
Modulates JAK-STAT Pathway in IL-12/IFN Gamma Axis Leading to Th1 Response in
Experimental Allergic Encephalomyelitis. Journal
of Neuroscience Research, 83, 1299-1309. https://doi.org/10.1002/jnr.20826
Jia,
Y., Jing, J., Bai, Y., Li, Z., Liu, L., Luo, J., Liu, M. and Chen,
H. (2011) Amelioration of Experimental
Autoimmune Encephalomyelitis by Plumbagin through Down- Regulation
of JAK-STAT and NF-κB Signaling Pathways. PLoS ONE, 6, e27006. https://doi.org/10.1371/journal.pone.0027006
Chen,
C., Liu, X., Wan, B. and Zhang, J.Z. (2009) Regulatory Properties of Copolymer
I in Th17 Differentiation by Altering STAT3 Phosphorylation. Journal of Immunology, 183, 246-253.
Wang, H., Brown, J., Garcia, C.A., Tang, Y., Benakanakere,
M.R., Greenway, T., Pascale, A., Denis, F.K. and Michael,
M. (2011). The Role of Glycogen Synthase Kinase 3 in Regulating
IFN-Beta-Mediated IL-10 Production. Journal
of Immunology, 186, 675-684. https://doi.org/10.4049/jimmunol.1001473